Skip to content

Clinical trials

Phase 2 Hepatitis B, Chronic trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 2 Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20151
20171
20192
20201
20212
20221
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Gilead Sciences3
Brii Biosciences Limited2
AusperBio Therapeutics Inc.1
F-star Therapeutics, Inc.1
Hoffmann-La Roche1
National University Health System, Singapore1
Romark Laboratories L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic14
Hepatitis B10
Hepatitis3
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1
Disease Attributes1
Hepatitis, Chronic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.